These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 32768524

  • 1. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity.
    Chen D, Chou FJ, Chen Y, Tian H, Wang Y, You B, Niu Y, Huang CP, Yeh S, Xing N, Chang C.
    Cancer Lett; 2020 Dec 28; 495():100-111. PubMed ID: 32768524
    [Abstract] [Full Text] [Related]

  • 2. TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals.
    Qiu X, Zhu J, Sun Y, Fan K, Yang DR, Li G, Yang G, Chang C.
    Oncotarget; 2015 Jun 20; 6(17):15397-409. PubMed ID: 25980442
    [Abstract] [Full Text] [Related]

  • 3. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M, Sun Y, Xu J, Lu J, Wang K, Yang DR, Yang G, Li G, Chang C.
    Int J Cancer; 2018 Jul 01; 143(1):100-112. PubMed ID: 29396852
    [Abstract] [Full Text] [Related]

  • 4. Use of miR‑145 and testicular nuclear receptor 4 inhibition to reduce chemoresistance to docetaxel in prostate cancer.
    Zhu J, Qin P, Cao C, Dai G, Xu L, Yang D.
    Oncol Rep; 2021 Mar 01; 45(3):963-974. PubMed ID: 33650661
    [Abstract] [Full Text] [Related]

  • 5. Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression.
    Shi H, Sun Y, He M, Yang X, Hamada M, Fukunaga T, Zhang X, Chang C.
    Oncogene; 2020 Jan 01; 39(3):530-545. PubMed ID: 31501521
    [Abstract] [Full Text] [Related]

  • 6. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.
    Yang DR, Ding XF, Luo J, Shan YX, Wang R, Lin SJ, Li G, Huang CK, Zhu J, Chen Y, Lee SO, Chang C.
    J Biol Chem; 2013 Jun 07; 288(23):16476-16483. PubMed ID: 23609451
    [Abstract] [Full Text] [Related]

  • 7. TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression.
    Zhu J, Yang DR, Sun Y, Qiu X, Chang HC, Li G, Shan Y, Chang C.
    Mol Cancer Ther; 2015 Jun 07; 14(6):1445-53. PubMed ID: 25833838
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
    Dai Y, Wu Z, Lang C, Zhang X, He S, Yang Q, Guo W, Lai Y, Du H, Peng X, Ren D.
    Theranostics; 2019 Jun 07; 9(21):6063-6079. PubMed ID: 31534537
    [Abstract] [Full Text] [Related]

  • 11. TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth.
    Shen J, Lin H, Li G, Jin RA, Shi L, Chen M, Chang C, Cai X.
    Oncotarget; 2016 May 31; 7(22):32088-99. PubMed ID: 27050071
    [Abstract] [Full Text] [Related]

  • 12. miR-144-3p increases radiosensibility of gastric cancer cells by targeting inhibition of ZEB1.
    Gao ZY, Liu H, Zhang Z.
    Clin Transl Oncol; 2021 Mar 31; 23(3):491-500. PubMed ID: 32613412
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
    Zhang G, Tian X, Li Y, Wang Z, Li X, Zhu C.
    Biomed Pharmacother; 2018 Jan 31; 97():736-744. PubMed ID: 29102917
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression.
    Chou FJ, Chen Y, Chen D, Niu Y, Li G, Keng P, Yeh S, Chang C.
    EBioMedicine; 2019 Feb 31; 40():504-516. PubMed ID: 30692044
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. TR4 nuclear receptor suppresses HCC cell invasion via downregulating the EphA2 expression.
    Jin R, Lin H, Li G, Xu J, Shi L, Chang C, Cai X.
    Cell Death Dis; 2018 Feb 15; 9(3):283. PubMed ID: 29449527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.